A 59-year-old male patient developed a new 4 cm × 6 cm cavitary left upper lung lesion over a 2 months period. The patient had a prior history of a surgically resected Stage IA non-small cell lung cancer in the right upper lobe 3 years prior. He was treated for possible infection with radiographic improvement on subsequent imaging. Further imaging after 3 months revealed an oval soft tissue density within the cavity with air crescent sign \[[Figure 1](#F1){ref-type="fig"}\]. Bronchoscopy with transbronchial biopsies showed an acute and chronic granulomatous inflammation. *Aspergillus fumigatus* was noted on culture and voriconazole was initiated.\[[@ref1]\] Subsequent imaging showed initial improvement and then the stability of cavity size. However, 11 months later, the medial wall of the cavity showed increased thickness. Bronchoscopy showed no endobronchial lesions \[[Figure 2](#F2){ref-type="fig"}\]. Esophageal ultrasound-guided fine-needle aspiration using the endobronchial curvilinear endoscopic ultrasound bronchoscope was performed for a sampling of the cavity wall that was abutting the mediastinum \[[Figure 3](#F3){ref-type="fig"}\]. The aspirate showed squamous cell lung cancer and the patient was started on therapy after appropriate staging.\[[@ref2]\]

![Computed tomography scan of lung shows the cavity (thick arrow) with aspergilloma in the center (yellow). The thickened tumor wall (red arrow) abuts the mediastinum and the esophagus (green arrow)](EUS-6-210-g001){#F1}

![Tumor as seen using the ultrasound probe of the endobronchial ultrasound scope](EUS-6-210-g002){#F2}

![Real-time biopsy with needle (red arrow) inside tumor](EUS-6-210-g003){#F3}
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